The recognition highlights a climate venture capitalist who built a high-performing institutional fund and is now deploying that same investment discipline to change what the world measures, from the ...
Fully wiping out the gains from last week, crude oil prices have gone into a tailspin on Monday after U.S. President Donald Trump downplayed the possibility for fresh strikes ...
Guardix published a one-minute product walkthrough on October 17, 2026, showing how private security companies can use AI to prepare officer schedules ...
Luc Broussaud joins exclusive Supernova Hall of Fame, while Jaggaer customers Betsson Group and Signify are finalists for innovation Jaggaer, a global leader in AI-powered source-to-pay and supplier ...
The registration reinforces PhotonPay's regulatory foundation for payment activities in Canada, with requirements covering operational risk management, incident response and the safeguarding of end-us ...
A new report from Mentimeter examines why valuable knowledge inside organizations often fails to reach the people who can act on it, and what leaders can do to change that. The findings point to an ...
Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) ("Standard Uranium" or the "Company") is pleased to announce that it has ...
WELL achieved quarterly revenue of $407.4 million in Q3-2026, an increase of 12% compared to Q3-2025, driven by strong growth in the Company's Canadian Patient Services business where quarterly revenu ...
Jurate Keblyte to become Chief Financial Officer of RENK Group AG from March 2027 Anja Mänz-Siebje will not be extending her current Executive Board contract and will pass on her role as CFO to ...
The 5-million-euro investment will strengthen fermentation and downstream processing operationsALBANY, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Curia Global Inc. (Curia), a global contract research, de ...
AI licensing revenues, with multi-year smartphone modem ramp ahead ROCKVILLE, Md., Nov. 9, 2026 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor ...
Lifordi Immunotherapeutics, Inc., a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results